Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATORVO: Atorvastatin in Retinal Vein Occlusion
NCT00517257Phase 3Unknown
- Sponsor
- University of Toronto
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in retinal vein occlusion (RVO), sponsored by University of Toronto. Status: unknown.
02
Drugs
atorvastatin
03
Conditions
retinal vein occlusion (RVO)
Beyond the preview
Go deeper on NCT00517257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517257.